Please check your internet connection and try again.
# Walethmade bromide
## Overview
Walethmade bromide is a synthetic anticholinergic agent.
## Primary Indications
Walethmade bromide is primarily used for the symptomatic treatment of parkinsonism, including drug-induced extrapyramidal symptoms.
## Adult Dosing
* **Parkinsonism:** Usual starting dose is 5 mg to 10 mg orally once or twice daily. Doses can be increased gradually based on response and tolerability, up to a maximum of 15 mg three times daily.
* **Drug-induced Extrapyramidal Symptoms:** Usual starting dose is 5 mg to 10 mg orally once or twice daily. Doses can be increased gradually based on response and tolerability, up to a maximum of 15 mg three times daily.
Dosing should be individualized based on patient response and tolerance.
## Pediatric Dosing
There is no established pediatric dosing for Walethmade bromide. Safety and efficacy have not been determined in pediatric populations.
## Dose Adjustments
* **Hepatic Impairment:** No specific dose adjustments are routinely recommended, but caution and close monitoring for adverse effects are advised due to potential impaired metabolism.
* **Renal Impairment:** No specific dose adjustments are routinely recommended, but caution and close monitoring for adverse effects are advised due to potential reduced excretion.
## Contraindications
* Hypersensitivity to Walethmade bromide or any component of the formulation.
* Glaucoma (specifically narrow-angle glaucoma).
* Myasthenia gravis.
* Prostatic hypertrophy or bladder neck obstruction.
* Tachyarrhythmias.
* Known history of pyloric or duodenal obstruction.
## Adverse Effects
Common adverse effects include dry mouth, blurred vision, constipation, urinary retention, drowsiness, confusion, dizziness, and tachycardia. Less common but serious effects may include hallucinations, cognitive impairment, and gastrointestinal stasis.
## Key Drug Interactions
* **Other Anticholinergics:** Additive anticholinergic effects, increasing the risk of adverse events.
* **CNS Depressants (e.g., alcohol, opioids, benzodiazepines):** Additive sedation and CNS depression.
* **MAO Inhibitors:** May potentiate anticholinergic effects.
* **Amantadine:** Increased risk of anticholinergic side effects.
* **Potassium Chloride:** Slow-release potassium chloride preparations can cause gastrointestinal ulceration, which may be exacerbated by the decreased motility caused by anticholinergics.
## Monitoring
* Monitor for signs and symptoms of anticholinergic toxicity (e.g., dry mouth, blurred vision, urinary retention, constipation, cognitive changes).
* Assess for improvement in parkinsonian symptoms or drug-induced extrapyramidal symptoms.
* Monitor vital signs, especially heart rate.
## Clinical Pearls
* Titrate dose slowly to minimize anticholinergic side effects, especially in elderly patients.
* Advise patients to avoid operating heavy machinery or driving until they know how Walethmade bromide affects them due to potential for drowsiness and blurred vision.
* Manage constipation with increased fluid and fiber intake, and consider stool softeners if necessary.
* Caution is advised in patients with a history of cardiac disease due to potential for tachycardia.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete and definitive guidance before initiating or modifying therapy. Local protocols may vary.
